Search Results - "Gedikli, Esra"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings by Barış, Veysel Özgür, Gedikli, Esra, Yersal, Nilgün, Müftüoğlu, Sevda, Erdem, Ayşen

    Published in Amino acids (01-11-2019)
    “…Doxorubicin (DOXO) may cause serious cardiotoxic effects that limit its use as an antineoplastic agent. We aimed to evaluate the protective role of taurine…”
    Get full text
    Journal Article
  2. 2

    Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways by Barış, Veysel Özgür, Dinçsoy, Adnan Berk, Gedikli, Esra, Zırh, Selim, Müftüoğlu, Sevda, Erdem, Ayşen

    Published in Cardiovascular toxicology (01-09-2021)
    “…Empagliflozin (EMPA) is a SGLT-2 inhibitor that has positive effects on cardiovascular outcomes. In this study, we aim to evaluate the possible protective…”
    Get full text
    Journal Article
  3. 3

    Taurine Protects Doxorubicin-Induced Hepatotoxicity via Its Membrane-Stabilizing Effect in Rats by Gedikli, Esra, Barış, Veysel Özgür, Yersal, Nilgün, Dinçsoy, Adnan Berk, Müftüoğlu, Sevda Fatma, Erdem, Ayşen

    Published in Life (Basel, Switzerland) (01-10-2023)
    “…Background: Doxorubicin (dox) is a chemotherapeutic agent widely used against various tumors. However, the clinical use of this agent is limited due to various…”
    Get full text
    Journal Article
  4. 4

    Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication by Barış, Veysel özgür, Gedikli, Esra, Dinçsoy, Adnan Berk, Erdem, Ayşen

    Published in Cardiovascular Journal of Africa (01-09-2024)
    “…\r\nAim:\r\nEmpagliflozin (EMPA) is a sodium-glucose transporter-2 inhibitor used in the treatment of type 2 diabetes and has positive effects on…”
    Get full text
    Journal Article
  5. 5

    Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats by Özgür Barış, Veysel, Dinçsoy, Berk, Gedikli, Esra, Erdemb, Ayşen

    Published in Kardiologia polska (25-01-2021)
    “…Sotalol is a class III antiarrhythmic drug commonly used in various arrhythmia treatments. However, due to its potent potassium channel inhibition, it can…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Protective Role of Erdosteine Pretreatment on Oleic Acid-Induced Acute Lung Injury by Erdem, Ayşen, Gedikli, Esra, Yersal, Nilgün, Karaismailoglu, Serkan, Muftuoglu, Sevda, Fadillioglu, Ersin, Tuncer, Meltem

    Published in The Journal of surgical research (01-06-2017)
    “…Abstract Background Erdosteine is a mucolytic agent with antioxidant and anti-inflammatory effects. We evaluated the protective effect of erdosteine…”
    Get full text
    Journal Article